February 18, 2009 - MEDRAD’s Intego PET Infusion System has been named one of Medical Imaging Magazine’s top eight most innovative products of the year.

The magazine designated its top eight based on what its readership considers to be the most far-reaching, game changing or otherwise groundbreaking medical devices on the market.

MEDRAD’s Intego PET infusion system automatically measures and delivers patient-specific Fluorodeoxyglucose (FDG) doses on demand. With on-board dosimetry, the system reportedly can deliver precise, repeatable FDG doses within +/- 2 percent of the measured dose. The Intego also minimizes FDG handling and is fully-shielded, reducing radiation exposure by more than 20 percent compared to conventional (syringe-based) FDG delivery methods.

For more information: www.medrad.com/FDGdelivery


Additional Content

News | Contrast Media

Oct. 27, 2026 – Bracco has announced plans to invest $230 million to establish its first U.S. manufacturing facility for ...

Time October 28, 2026
arrow
News | Molecular Imaging

Editor's Note: This article has been updated to correct an earlier version. Oct. 15, 2026 — GE HealthCare has announced ...

Time October 16, 2026
arrow
News | Radiopharmaceuticals and Tracers

Oct. 5, 2026 — GE HealthCare has announced a definitive agreement to acquire SOFIE Biosciences, a U.S.-based CMO for PET ...

Time October 06, 2026
arrow
News | Cardiac Imaging

Aug. 11, 2026 — Bracco Imaging recently announced that VueJect, its dedicated ultrasound contrast delivery system ...

Time August 12, 2026
arrow
News | Contrast Agents

June 15, 2026 – Bayer has announced that the U.S. Food and Drug Administration (FDA) approved Ambelvist (gadoquatrane) ...

Time June 16, 2026
arrow
Subscribe Now